All companies
AIM:PRM · Health Care · Applied proteomics: biomarker contract research services and chemical (isobaric mass tag) reagents for the life sciences sector
Proteome Sciences plc logo

Proteome Sciences plc

Proteome Sciences plc is a UK-based applied proteomics company operating two businesses: a contract research (biomarker/proteomic services) business providing mass-spectrometry-based protein biomarker discovery, validation and chemoproteomics services to pharmaceutical, biotech and academic customers from UK, German (Frankfurt) and US (San Diego) laboratories; and a chemical reagents business that invented and licenses TMT®/TMTpro® isobaric mass tags exclusively to Thermo Fisher Scientific for royalty and product-sale income. The Group also holds biomarker patent licences (stroke diagnostics with Randox and Galaxy CCRO) and a minority equity stake in Galaxy CCRO.

Share price and financials

No price history · 11 reported years, FY2015–FY2025

No daily prices have been collected for this company.

LineFY2015lockedFY2016lockedFY2017lockedFY2018lockedFY2019lockedFY2020lockedFY2021lockedFY2022lockedFY202312/23FY202412/24FY202512/25
Revenue
Gross profit
Operating profit
Exceptional items——
Net finance cost
Profit before tax
Tax charge
Profit for the year
EBITDA
Basic EPS
Diluted EPS

GBP millions, negatives in brackets. Per-share lines in pence. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated.

2 figures

3 years, at a glance

GBP · %
02m4m6m-80%-70%-60%-50%-40%-30%FY2023FY2025

Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.

FY2025Revenue£3.8mOperating margin−71.0%